InfoPack

Recent JCP Articles on InfoPack

JCP
Original Research

July 9, 2025

VEGF levels were significantly higher in the first-episode psychosis group than in the control group. The preliminary results suggest that increase in VEGF might help preserve social cognition after...
, , , et al
JCP
A Case Series of Intimate Partner Violence in Older Adults
Original Research

July 9, 2025

This case series highlights the complexity in assessing and managing IPV in both members of the older adult dyad. Specific approaches are required given the interdependency often present in...
, ,
JCP
A Primer on Individual Participant Data Meta-Analysis and Its Strengths and Limitations
Clinical and Practical Psychopharmacology

July 7, 2025

This article discusses individual participant data meta-analysis, which differs from conventional meta-analysis in that the statistical team obtains and processes individual participant data from the source studies.

Recent PCC Articles on InfoPack

PCC
Mental Health Effects of Tirzepatide
Case Report

July 9, 2025

The authors describe 2 cases demonstrating the potential mental health benefits of tirzepatide, a GLP-1/GIP receptor agonist.
,
PCC
Serious Suicide Attempt Management
Rounds in the General Hospital

July 8, 2025

Approximately half of the individuals who take their own life have had contact with their primary care provider within the month before their death.
, , , et al
PCC
The Hidden Perils of Kratom
Case Report

July 8, 2025

This case highlights the toxic effects of high-dose kratom and subsequent management using second-generation antipsychotics
, ,

Featured InfoPack Research

Caplyta Shows Promise in Preventing Schizophrenia Relapse
news

July 9, 2025

Johnson & Johnson seeks FDA approval to expand Caplyta’s use for preventing schizophrenia relapse.
Could Smartphones Transform How We Diagnose Mental Health?
news

July 8, 2025

Smartphones could soon help detect early signs of mental health issues by passively tracking our behavior patterns.
PCC
Tirzepatide for Clozapine-Induced Weight Gain
Case Report

July 8, 2025

The authors describe a patient with schizophrenia who effectively reversed substantial clozapine-induced weight gain using tirzepatide, followed by weight regain after insurance-related discontinuation.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe